InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Dyrness Albert D., 董事. Insider active across 2 companies, notably Sonnet BioTherapeutics Holdings, Inc.. Aggregated, 8 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. History available since 30 May 2023. The latest transaction was disclosed on 9 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Dyrness Albert D. is Administrateur and a declarant at Sonnet BioTherapeutics Holdings, Inc. and Hyperliquid Strategies Inc. He has 8 filings in total, and among the recent filings available, buys total 10140 EUR, sells total 0 EUR, over the period from 2022-04-08 to 2026-02-11.